Advertisement

Advertisement

AU:ARX Stock Latest News

Aroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution

Company AnnouncementsAroa Biosurgery Flags Lapse and Expiry of Equity Incentives, Trimming Potential Dilution

Aroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers

PremiumCompany Announcements

Aroa Biosurgery’s Symphony Trial Hits Key Endpoint in Diabetic Foot Ulcers

11d ago

Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares

PremiumCompany Announcements

Aroa Biosurgery to Release Small Tranche of Escrowed Director Shares

17d ago

Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial

PremiumCompany Announcements

Aroa Biosurgery Targets Trauma Wound Market With New Phase 4 Myriad–NPWT Trial

2M ago

Aroa Biosurgery Seeks ASX Quotation for New Shares Issued Under Employee Incentive Scheme

PremiumCompany Announcements

Aroa Biosurgery Seeks ASX Quotation for New Shares Issued Under Employee Incentive Scheme

2M ago

Aroa Biosurgery Issues Investor-Focused February 2026 Business Update

PremiumCompany AnnouncementsAroa Biosurgery Issues Investor-Focused February 2026 Business Update

2M ago

Aroa Biosurgery Poised to Gain From US Reimbursement Shift as New Data Backs Myriad

Company Announcements

Aroa Biosurgery Poised to Gain From US Reimbursement Shift as New Data Backs Myriad

2M ago

Aroa Biosurgery’s Symphony Trial Completion: What Diabetic Ulcer Data Could Mean for AU:ARX

Company Announcements

Aroa Biosurgery’s Symphony Trial Completion: What Diabetic Ulcer Data Could Mean for AU:ARX

2M ago

Aroa Biosurgery Schedules Investor Webinar to Detail Symphony Reimbursement and Clinical Data

PremiumCompany Announcements

Aroa Biosurgery Schedules Investor Webinar to Detail Symphony Reimbursement and Clinical Data

2M ago

Aroa Biosurgery Study Backs Efficacy and Cost Edge of Myriad Trauma Scaffold

PremiumCompany Announcements

Aroa Biosurgery Study Backs Efficacy and Cost Edge of Myriad Trauma Scaffold

3M ago

Aroa Biosurgery Options Lapse Following Unmet Vesting Conditions

PremiumCompany Announcements

Aroa Biosurgery Options Lapse Following Unmet Vesting Conditions

3M ago

Aroa’s Symphony Wins Extended US Medicare Access as CMS Tightens Skin Substitute Rules

PremiumCompany Announcements

Aroa’s Symphony Wins Extended US Medicare Access as CMS Tightens Skin Substitute Rules

4M ago

Aroa Biosurgery Ltd Reports Half-Year 2026 Results

PremiumCompany AnnouncementsAroa Biosurgery Ltd Reports Half-Year 2026 Results

5M ago

Aroa Biosurgery Achieves Strong Revenue Growth and Financial Stability in H1 FY26

Company Announcements

Aroa Biosurgery Achieves Strong Revenue Growth and Financial Stability in H1 FY26

5M ago

Aroa Biosurgery Reports Improved Financial Performance Amid Sales Growth

Company Announcements

Aroa Biosurgery Reports Improved Financial Performance Amid Sales Growth

5M ago

Aroa Biosurgery Issues Unquoted Equity Securities for Employee Incentive

PremiumCompany Announcements

Aroa Biosurgery Issues Unquoted Equity Securities for Employee Incentive

5M ago

Aroa Biosurgery to Host Investor Event on H1 FY26 Results and Outlook

PremiumCompany Announcements

Aroa Biosurgery to Host Investor Event on H1 FY26 Results and Outlook

5M ago

Aroa Biosurgery Announces Director Departure and Securities Update

PremiumCompany Announcements

Aroa Biosurgery Announces Director Departure and Securities Update

5M ago

Aroa Biosurgery Announces Board Changes with New Appointment and Retirement

PremiumCompany Announcements

Aroa Biosurgery Announces Board Changes with New Appointment and Retirement

5M ago

Aroa Biosurgery’s Symphony™: A New Hope for Diabetic Foot Ulcers?

PremiumCompany AnnouncementsAroa Biosurgery’s Symphony™: A New Hope for Diabetic Foot Ulcers?

5M ago

Aroa Biosurgery’s Myriad™ Study: A Potential Game-Changer in Soft Tissue Reconstruction

Company Announcements

Aroa Biosurgery’s Myriad™ Study: A Potential Game-Changer in Soft Tissue Reconstruction

5M ago

Aroa Biosurgery Releases Q2 Cashflow Report Highlighting Regenerative Healing Focus

Company Announcements

Aroa Biosurgery Releases Q2 Cashflow Report Highlighting Regenerative Healing Focus

6M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >